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ヒトNK様培養細胞KHYG‐１の細胞傷害における細胞傷害性顆粒の分泌動態
安 藝 健 作１），三 輪 詩 佳２），佐 藤 瑞 樹３），曽 根 淳 美４），川 添 和 義５），





















































いる。現在までに，ヒト NK 細胞の IL‐２刺激による検
討で，主要細胞膜抗原である CD５６抗原の発現量と NK
細胞傷害性との間に正の相関を認め，NK 細胞の「活性
化・細胞傷害性」が NK 細胞膜上 CD５６抗原を指標とし
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て評価することが可能であることを報告している７）。ま












ヒト NK 様細胞培養株 KHYG‐１（effector cell : JCRB
細胞バンク），慢性骨髄性白血病細胞株 K５６２（target

















































時間刺激終了３０分前にウェルに LysoTracker Deep Red
























ルタ GFP を用い，励起/蛍光が６４７／６６８の LysoTracker
















グランザイム B を染色するため KHYG‐１細胞５×１０６個
/mL を５０µl に IntraPreP（BECKMAN COULTER）試
薬１と試薬２を加え，細胞膜透過処理を行った。
⑶グランザイム B の測定




























































細胞の代替細胞となる NK 様培養細胞 KHYG‐１におい
























図３ IL‐２刺激による KHYG‐１細胞内の Granzyme B 発現解析
Granzyme B発現量は，フローサイトメーターのGMFI
（Geometric Mean Fluorescence Intensity：幾何学的平均蛍
光強度）を指標に評価。mean±S.D., n＝５（*p＜０．０５）
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SUMMARY
Three major therapies, “surgery”, “chemotherapy”, and “radiotherapy”, have been used to treat
cancer. Recently, “immunotherapy” has attracted attention as the fourth treatment. We previously
performed fundamental studies using NK cells, one cell type that has attracted attention in
immunotherapy, and revealed that the surface CD５６antigen on the KHYG‐１ human NK cell-like
cultured cells as a substitute for human NK cells can be used as an evaluation index of NK cell
activity as in human NK cells. We also reported that the cytotoxicity of KHYG‐１increases by IL‐２
stimulation. In this study, we improved the conventional cytotoxicity measurement method to
evaluate the effects of a small amount of activator on NK cells. As a result, the cytotoxicity rate
and measurement sensitivity at low-concentration IL‐２stimulation were increased, and it became
possible to evaluate the effects of a smaller amount of the activator. In the dynamic observation of
KHYG‐１ intracellular granules, it was possible to observe in real time how the target cells were
damaged after the influx of granules. Furthermore, the relationship between the activation of
KHYG‐１and the change in the intracellular expression level of granzyme B by IL‐２stimulation was
clarified, and future research tasks were shown.
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